Drug intelligence / Profile preview

Fertomcidina U

Development stage: Unknown
Lead developer: AOU Città della Salute e della Scienza di Torino
Modality: Small Molecules
Administration: Topical

Overview

Fertomcidina U is a topical antiseptic solution primarily used for the treatment of oral mucosal lesions, including recurrent aphthous stomatitis, gingivitis, and periodontitis. It is a complex formulation containing iodine, sulfuric acid, and nitric acid. The drug exerts its therapeutic effect through the broad-spectrum antimicrobial properties of iodine, which oxidizes essential biological molecules in pathogens, while the acidic components may assist in the cleansing and debridement of the affected tissue. It has been evaluated in Phase 4 clinical trials comparing its efficacy to chlorhexidine for symptom relief and lesion healing in patients with minor aphthous ulcers.

Brand names: Fertomcidina U

Targets

Neuraminidase

Beyond the preview

Go deeper on Fertomcidina U.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fertomcidina U.

Explore the full profile